PURPOSE: To determine the concentration of myocilin in primary open-angle glaucoma (POAG) and pseudoexfoliation glaucoma (PEXG) aqueous humor. METHODS: Aqueous humor was collected during surgery from patients with POAG, PEXG, and elective cataract removal (control). Volume-equivalent aqueous samples were separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis gradient gels. Quantification of myocilin levels was performed using Western blots probed with 2 independent N-terminal polyclonal anti-myocilin antibodies (AB1 and AB2) followed by densitometry. Myocilin levels in aqueous humor were quantified by plotting the densitometry readings of the aqueous samples against a recombinant myocilin standard curve. Total protein concentration was determined by Bradford protein assay. Transforming growth factor β 2 levels were assessed by enzyme-linked immunosorbent assay. RESULTS: Myocilin levels are significantly elevated in human POAG aqueous humor when compared with control aqueous humor (AB1: 0.66±0.53 ng/μL vs. 0.23±0.20 ng/μL, P<0.001; AB2: 0.98±0.59 ng/μL vs. 0.65±0.5 ng/μL, P<0.03; mean±SD). Myocilin makes up a larger percent of the total protein in POAG aqueous humor compared with control aqueous (AB1: 0.26±0.20% vs. 0.10±0.20%, P<0.001; AB2: 0.43±0.32% vs. 0.28±0.18%, P<0.05). In contrast to POAG, myocilin levels were not elevated in PEXG aqueous humor when compared with control aqueous humor. No correlation between myocilin and transforming growth factor β 2 levels was observed. CONCLUSIONS: Myocilin is elevated in POAG, but not in PEXG aqueous humor.
PURPOSE: To determine the concentration of myocilin in primary open-angle glaucoma (POAG) and pseudoexfoliation glaucoma (PEXG) aqueous humor. METHODS: Aqueous humor was collected during surgery from patients with POAG, PEXG, and elective cataract removal (control). Volume-equivalent aqueous samples were separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis gradient gels. Quantification of myocilin levels was performed using Western blots probed with 2 independent N-terminal polyclonal anti-myocilin antibodies (AB1 and AB2) followed by densitometry. Myocilin levels in aqueous humor were quantified by plotting the densitometry readings of the aqueous samples against a recombinant myocilin standard curve. Total protein concentration was determined by Bradford protein assay. Transforming growth factor β 2 levels were assessed by enzyme-linked immunosorbent assay. RESULTS:Myocilin levels are significantly elevated in human POAG aqueous humor when compared with control aqueous humor (AB1: 0.66±0.53 ng/μL vs. 0.23±0.20 ng/μL, P<0.001; AB2: 0.98±0.59 ng/μL vs. 0.65±0.5 ng/μL, P<0.03; mean±SD). Myocilin makes up a larger percent of the total protein in POAG aqueous humor compared with control aqueous (AB1: 0.26±0.20% vs. 0.10±0.20%, P<0.001; AB2: 0.43±0.32% vs. 0.28±0.18%, P<0.05). In contrast to POAG, myocilin levels were not elevated in PEXG aqueous humor when compared with control aqueous humor. No correlation between myocilin and transforming growth factor β 2 levels was observed. CONCLUSIONS:Myocilin is elevated in POAG, but not in PEXG aqueous humor.
Authors: N Jacobson; M Andrews; A R Shepard; D Nishimura; C Searby; J H Fingert; G Hageman; R Mullins; B L Davidson; Y H Kwon; W L Alward; E M Stone; A F Clark; V C Sheffield Journal: Hum Mol Genet Date: 2001-01-15 Impact factor: 6.150
Authors: E M Stone; J H Fingert; W L Alward; T D Nguyen; J R Polansky; S L Sunden; D Nishimura; A F Clark; A Nystuen; B E Nichols; D A Mackey; R Ritch; J W Kalenak; E R Craven; V C Sheffield Journal: Science Date: 1997-01-31 Impact factor: 47.728
Authors: Stéphane Gobeil; Marc-André Rodrigue; Steve Moisan; Thai D Nguyen; Jon R Polansky; Jean Morissette; Vincent Raymond Journal: Invest Ophthalmol Vis Sci Date: 2004-10 Impact factor: 4.799
Authors: E O MacKay; M E Kallberg; K P Barrie; W Miller; J S Sapienza; H Denis; F J Ollivier; C Plummer; T Rinkoski; N Scotty; K N Gelatt Journal: Vet Ophthalmol Date: 2008 Jul-Aug Impact factor: 1.644
Authors: Joshua T Morgan; Heung Sun Kwon; Joshua A Wood; Dori L Borjesson; Stanislav I Tomarev; Christopher J Murphy; Paul Russell Journal: Exp Eye Res Date: 2015-02-24 Impact factor: 3.467
Authors: Uttio Roy Chowdhury; Benjamin J Madden; Mary Christine Charlesworth; Michael P Fautsch Journal: Invest Ophthalmol Vis Sci Date: 2010-05-12 Impact factor: 4.799
Authors: Laura P Cohen; Jessica Wong; Aliya Z Jiwani; Scott H Greenstein; Stacey C Brauner; Sherleen C Chen; Angela V Turalba; Teresa C Chen; Lucy Shen; Douglas J Rhee; Janey L Wiggs; Jae Hee Kang; Stephanie Loomis; Louis R Pasquale Journal: Digit J Ophthalmol Date: 2014-06-30
Authors: John Kuchtey; Uttio Roy Chowdhury; Colby C Uptegraft; Michael P Fautsch; Rachel W Kuchtey Journal: Eur J Med Genet Date: 2013-03-19 Impact factor: 2.708
Authors: José-Daniel Aroca-Aguilar; Ana Fernández-Navarro; Jesús Ontañón; Miguel Coca-Prados; Julio Escribano Journal: PLoS One Date: 2018-12-17 Impact factor: 3.240